DR SMITA RAMACHANDRAN
Salt and Blood pressure problem in newborns : Let’s understand CAH !
Congenital Adrenal Hyperplasia (CAH) is a genetic condition affecting hormone production in the adrenal...
Osteogenesis Imperfecta (OI), commonly known as “Brittle Bone Disease,” is a genetic connective tissue disorder characterized by fragile bones that fracture easily under minimal mechanical stress. Modern pediatric endocrine therapies, physical rehabilitation, and specialized orthopedic support now enable children with OI to build stronger bone density and achieve mobility.
Osteogenesis Imperfecta is caused by genetic mutations that impair the production or structural assembly of Type 1 Collagen, the major structural protein forming bone matrix, ligaments, tendons, sclera, and teeth.
Approximately 85% to 90% of cases result from autosomal dominant mutations in the COL1A1 and COL1A2 genes. Severity ranges from mild forms with occasional fractures in childhood to severe neonatal forms presenting with intrauterine fractures.
In addition to recurring fractures, children with OI often present with multisystem collagen-related features:
Multiple low-impact fractures, family history of brittle bones, and clinical examination of sclera, teeth, and joints.
Generalized osteopenia, thin cortical bone, “popcorn” calcifications at epiphyses, and vertebral compression deformities.
Serial dual-energy X-ray absorptiometry measuring lumbar spine bone density Z-scores.
Comprehensive next-generation sequencing panel confirming specific COL1A1/COL1A2 mutations for tailored prognostic planning.
Comprehensive multidisciplinary management focuses on strengthening bone, preventing deformities, and optimizing physical ability:
With specialized pediatric endocrine therapy and proactive orthopedic support, children with Osteogenesis Imperfecta can attend mainstream schools, enjoy active friendships, and lead fulfilling lives.
Consult our specialist for personalised guidance and care.